https://www.urjc.es/todas-las-noticias-de-actualidad/8691-nuevo-farmaco-experimental-para-controlar-la-hipertension
The INVASC research group, led by professors from our Faculty, has demonstrated the beneficial effect of a new compound derived from melatonin for the treatment of cardiovascular disorders associated with high blood pressure.